Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis

      Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis

      Medical Dialogues Bureau1 Jun 2019 2:39 PM IST
      New Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
      Apollo Hospitals Q4 revenue, Net Profit up, EBITDA crosses Rs 1000 crore milestone

      Apollo Hospitals Q4 revenue, Net Profit up, EBITDA crosses Rs 1000 crore milestone

      Medical Dialogues Bureau1 Jun 2019 2:36 PM IST
      Apollo Hospitals has delivered a strong performance in the final quarter of the year, with the continued growth of volumes, revenues and margins....
      36 e-cigarette brands illegally operating in India: Survey

      36 e-cigarette brands illegally operating in India: Survey

      Medical Dialogues Bureau1 Jun 2019 2:34 PM IST
      New Delhi: Even as the union health ministry continues its efforts to prevent the entry of e-cigarette companies into India, the latest survey has...
      Lupins Goa facility may face regulatory action, says USFDA

      Lupin's Goa facility may face regulatory action, says USFDA

      Medical Dialogues Bureau31 May 2019 4:25 PM IST
      New Delhi: Drug maker Lupin Thursday said the US health regulator has cautioned that the firm's Goa facility may be subject to regulatory or...
      Philadelphia : Pharma company settles claims of kickbacks to dermatologists

      Philadelphia : Pharma company settles claims of kickbacks to dermatologists

      Medical Dialogues Bureau31 May 2019 4:25 PM IST
      PHILADELPHIA - The U.S. attorney's office in Philadelphia says a pharmaceutical company is agreeing to pay $3.5 million to settle claims it paid...
      Faulty hip implants Johnson and Johnson directed to pay Rs 25 Lakh to 67 patients who had revision surgery

      Faulty hip implants Johnson and Johnson directed to pay Rs 25 Lakh to 67 patients who had revision surgery

      Medical Dialogues Bureau31 May 2019 3:34 PM IST
      The Central Drugs Standard Control Organisation (CDSCO) had earlier asked the company Johnson and Johnson to pay Rs 65 lakh, Rs 74 lakh, Rs 1 crore...
      Aster DM Healthcare Q4 net profit up 7.1 percent to Rs 219.84 crore

      Aster DM Healthcare Q4 net profit up 7.1 percent to Rs 219.84 crore

      Medical Dialogues Bureau31 May 2019 9:30 AM IST
      "We are very happy to report strong growth at both the top line and EBITDA (Earnings before interest, tax, depreciation and amortisation) level. All...
      Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis

      Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis

      Medical Dialogues Bureau30 May 2019 5:12 PM IST
      Kyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
      Addressable medicine market for e-pharmacies in India likely to reach $18.1 billion by 2023: Report

      Addressable medicine market for e-pharmacies in India likely to reach $18.1 billion by 2023: Report

      Medical Dialogues Bureau30 May 2019 9:45 AM IST
      This expected rise in the acute target market by e-pharmacies, can be attributed to an improvement in last-mile logistics through collaboration with...
      Cadila Healthcare posts Q4 net profit of Rs 460 crore

      Cadila Healthcare posts Q4 net profit of Rs 460 crore

      Medical Dialogues Bureau30 May 2019 9:15 AM IST
      The consolidated financial statements for the quarter and the year ended March 31, 2019, including the operations of Heinz India Pvt Ltd (HIPL) for...
      Misleading information on vaccines should be taken down from social media: Vaccine Chief

      Misleading information on vaccines should be taken down from social media: Vaccine Chief

      Medical Dialogues Bureau30 May 2019 9:00 AM IST
      Among the measures being taken to inoculate populations against the spread of misinformation about vaccine safety was putting pressure on social media...
      Mallinckrodt Amitiza to stay with branded business after spin-off

      Mallinckrodt Amitiza to stay with branded business after spin-off

      Medical Dialogues Bureau29 May 2019 9:15 AM IST
      The company said that it believed the new generics company, which will be called Mallinckrodt Inc, would emerge with less debt than previously...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok